JVJean-Charles Vauthier

Jean-Charles Vauthier

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jean-Charles Vauthier has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Glycemic meritocracy, sport and care: Between lay expertise and medical recognition.

    by Jean-Charles Vauthier, Bernard Kabuth

    To explore the physician-patient relationship among individuals with type 1 diabetes engaged in extreme endurance sports, highlighting dynamics of recognition, autonomy, and negotiation in care. Qualitative study based on thirteen semi-structured interviews with French-speaking runners living with type 1 diabetes. Analysis followed a constructivist grounded theory approach, with inductive coding and triangulation. The findings reveal a complex relational dynamic structured by gaps in medical expertise, the emergence of experiential autonomy, evolving forms of collaboration, and persistent structural constraints. These dynamics reflect a tension between standardized biomedical knowledge and situated, experience-based practices. Recognition of patient expertise appears conditional, often depending on the ability to maintain acceptable glycemic outcomes. This study identifies an implicit model, termed glycemic meritocracy, in which patient autonomy and legitimacy are shaped by conformity to biomedical norms. These findings highlight the need to move beyond performance-based evaluations of care and to more fully integrate experiential knowledge into clinical practice, particularly in complex or atypical contexts.

  • Vivre et courir avec un diabète de type 1 : le soin en mouvement

    by Jean-Charles Vauthier

    Cette thèse explore le vécu de personnes atteintes de diabète de type 1 (DT1) engagées dans des pratiques d'endurance et d'ultra-endurance, à travers une approche qualitative fondée sur la théorisation ancrée. Elle interroge la manière dont ces coureurs négocient les contraintes de la maladie, construisent des savoirs expérientiels et reconfigurent leur identité dans des contextes extrêmes. Treize entretiens semi-directifs ont été réalisés auprès de coureurs francophones ayant complété au moins un marathon ou une course d'ultra-endurance. L'analyse inductive a permis de dégager quatre dimensions majeures.1. Communautés de pairs et savoirs partagés. Les coureurs s'appuient sur des réseaux informels, souvent numériques, pour échanger des conseils pratiques, partager des récits et trouver un soutien émotionnel. Ces communautés compensent les lacunes des recommandations médicales standardisées et favorisent une logique d'apprentissage collectif, où l'expérience vécue prime sur les modèles prescriptifs.2. Trajectoires identitaires et ultra-endurance. La pratique sportive apparaît comme un espace de dépassement et de reconstruction identitaire. L'annonce du diagnostic, vécue comme une rupture biographique, cède progressivement la place à une réappropriation du corps et de la maladie. L'ultra-endurance devient un levier de résilience et de visibilité, permettant aux coureurs de transformer la vulnérabilité en compétence et en affirmation de soi.3. Relation de soin et méritocratie glycémique. Les récits révèlent une tension entre expertise médicale et savoir profane. Si certains soignants évoluent vers une posture collaborative, la reconnaissance de l'autonomie reste souvent conditionnée à la conformité aux normes biologiques. Cette logique, que nous qualifions de « méritocratie glycémique », interroge les fondements éthiques du soin et appelle à une reconnaissance pleine des savoirs expérientiels.4. Technologies : entre promesse et ambivalence. Les dispositifs connectés (CGM, pompes, boucles fermées) offrent un gain de sécurité et d'autonomie, mais introduisent une charge mentale persistante et une dépendance matérielle. Leur fragilité en contexte extrême impose des stratégies de redondance et d'improvisation, révélant une autonomie située, fondée sur la robustesse plutôt que sur la performance.Ces résultats mettent en lumière la pluralité des trajectoires et des stratégies, la centralité des savoirs expérientiels et la nécessité de penser l'autonomie comme un processus relationnel et contextuel. Ils invitent à dépasser une vision normative du « patient modèle » pour promouvoir des modèles de soin inclusifs, intégrant les récits, les communautés et les pratiques situées. Au-delà du DT1, cette recherche ouvre des perspectives pour la formation des soignants, la conception des technologies et la reconnaissance des savoirs profanes dans la gouvernance des soins chroniques

  • Open Access

    Diabetes Technologies in Ultra-Endurance Type 1 Diabetes: Qualitative Study

    by Jean-Charles Vauthier, Lucie Choley, Delphine Arduini, Patrick Mas, Bernard Kabuth

    Background: Diabetes technologies—including continuous glucose monitoring (CGM), insulin pumps, and hybrid closed-loop systems—have profoundly transformed self-management in type 1 diabetes (T1D). While these technologies offer improved glycemic control and safety, their use in ultraendurance sports introduces specific cognitive, material, and organizational challenges that remain underexplored in digital health research. Objective: This study aimed to explore how adults living with T1D experience and use diabetes technologies in ultraendurance sports, with particular attention to tensions between autonomy, mental load, and vulnerability. Methods: We conducted semistructured interviews with 13 French-speaking adults with T1D who had completed at least one marathon or ultra-endurance event within the last 5 years and used ≥1 diabetes technology (CGM, pump, or hybrid closed loop). We adopted constructivist grounded theory (Charmaz), using iterative cycles of line-by-line and focused coding, constant comparison, and memo-writing to build and refine analytic categories. Sampling combined purposive strategies through associations and online communities with theoretical orientation (additional participants sought to elaborate emergent categories). Data collection ceased upon theoretical sufficiency, when further interviews no longer yielded substantively new insights for core categories. Two patient partners contributed to question framing, interim sense-checking, and manuscript review. Reporting followed the COREQ (Consolidated Criteria for Reporting Qualitative Research) checklist. Results: Five interrelated categories described how athletes negotiated technology in practice: (1) From episodic control to continuous anticipation (reframing glucose management through real-time visibility); (2) Gains in safety and performance (perceived benefits and expanded possibilities); (3) Redistributed mental work (hyper-vigilance, logistics, device management); (4) Keeping things working when they break (fragility in extreme conditions, redundancy, improvisation, and experiential expertise); and (5) Making diabetes visible (technologies mediating identity, solidarity, and stigma). Across categories, participants articulated a tension between optimization-oriented performance and a user-constructed robustness—the capacity to maintain function under uncertainty through redundancy and adaptive know-how. Conclusions: In ultraendurance contexts, diabetes technologies act as both enablers and obligations: they open participation while shifting and sometimes intensifying cognitive and organizational work. A grounded account centered on robustness-in-use highlights practical implications for clinicians (pre-event routines, redundancy planning), designers (context-aware algorithms; improved physical durability), and policy makers (equitable access and exercise-specific education). These findings underscore the value of constructivist, practice-oriented inquiry to inform digital health tool design and support for people living with chronic illness.


  • Open Access

    Chronic illness and extreme performance: Type 1 diabetes in ultra-endurance

    by Jean-Charles Vauthier, Lucie Choley, Bernard Kabuth

    Background: This study explores how people with type 1 diabetes experience ultra-endurance sports, focusing on identity, self-management, and psychosocial impacts through a qualitative approach. Methods and findings: This qualitative study used a constructivist grounded theory approach. Thirteen semi-structured interviews were conducted with French-speaking adults living with T1D who had completed at least one marathon or ultra-endurance race. Data were analyzed inductively through line-by-line coding, focused coding, and thematic categorization, supported by NVivo® software and reported in accordance with COREQ guidelines. Four major themes emerged: (1) a progressive process of acceptance, from the shock of diagnosis to identity integration; (2) the ambivalence of being “ill,” with tensions between medical status and personal identity; (3) the mental load of diabetes management, intensified by ultra-endurance but mitigated by adaptive strategies and peer support; and (4) sport as a transformative space for self-affirmation, resilience, and advocacy. Participants described how ultra-endurance helped them reclaim agency, reframe their illness, and inspire others. Conclusions: Ultra-endurance sports offer a unique context for identity reconstruction and empowerment among people with T1D. Far from being a barrier, the illness can become a driver of personal growth and social visibility. These findings highlight the importance of recognizing experiential knowledge in chronic disease management and call for more inclusive, patient-centered approaches in healthcare and research.


  • Open Access

    Navigating Diabetes Technologies in Ultra-Endurance: Between Expected Performance and Lived Robustness (Preprint)

    by Jean-Charles Vauthier, Lucie Choley, Delphine Arduini, Patrick Mas, Bernard Kabuth

    BACKGROUND Diabetes technologies such as CGMs, insulin pumps, and closed-loop systems have transformed self-management practices. In ultra-endurance contexts, these tools offer refined glycemic control but introduce new logistical, cognitive, and social constraints. OBJECTIVE To explore the technological experiences of individuals with type 1 diabetes engaged in ultra-endurance sports, focusing on tensions between autonomy, mental load, and material vulnerability. METHODS A qualitative study was conducted using semi-structured interviews with 13 participants. Transcripts were analyzed through inductive thematic analysis, with double coding and triangulation. Five major themes were identified. Patient partners were involved throughout the research process, including the co-construction of the research question, feedback on interim findings, and review of the final manuscript. Methodological rigor was ensured using the COREQ checklist. RESULTS Five key dimensions emerged: technological evolution, perceived benefits, mental load, management of the unexpected, and social visibility. Participants described a tension between the promise of autonomy and the realities of technological dependence, vigilance, and fragility. CONCLUSIONS This study highlights the ambivalences of connected care in extreme sports contexts. It offers a critical perspective on bio-tracking and invites reflection on robust, situated, and sustainable autonomy in digital health. CLINICALTRIAL Not applicable – This is a qualitative study and does not involve a clinical trial requiring registration.

  • Open Access

    Increased risk of acute kidney injury in the first part of an ultra‐trail—Implications for abandonment

    by Jean‐Charles Vauthier, Charlie Touze, Benoit Mauvieux, Corentin Hingrand, Pierre‐Louis Delaunay, Stéphane Besnard, Romain Jouffroy, Philippe Noirez, Patrice Maboudou, Cassandra Parent, et al.

    Acute kidneys injuries (AKIs) have been described in marathon and trail running. The currently available data allows assessment of before/after comparisons but does not allow an analysis of what happens during the race. A multidisciplinary assessment protocol was performed during the first trail of Clécy (Normandy France) in November 2021. This allowed an initial assay to be carried out, then at the end of each of the 6 loops of 26 km, and finally after 24 h of recovery. The race extends over 156 km in hilly terrain and 6000 m of elevation gain (D+). The level of impairment according to the RIFLE classification was defined for each runner at each assay. Fifty‐five runners were at the start, and the per protocol analysis involved 36 runners (27 men and 9 women, 26 finishers). Fifteen (41.7%) of the riders presented at least one result corresponding to a “RIFLE risk” level. After 24 h of rest, only one runner still had a “RIFLE Risk”. The distance around the marathon seems to be the moment of greatest risk. For the first time, we find an association between this renal risk and the probability of abandonment. Many runners are vulnerable to kidney damage during long‐duration exercise, which is why it's important to limit risk situations, such as the use of potentially toxic drugs or hydration disorders. The consumption of NSAIDs (nonsteroidal anti‐inflammatory drugs) before or during an ultra‐distance race should therefore be prohibited. Attention should be paid to hydration disorders.


  • Glycaemic Effects of a 156-km Ultra-trail Race in Athletes: An Observational Field Study

    by Cassandra Parent, Benoît Mauvieux, Elodie Lespagnol, Corentin Hingrand, Jean-Charles Vauthier, Philippe Noirez, Rémy Hurdiel, Quentin Martinet, Pierre-Louis Delaunay, Stéphane Besnard, et al.

    Background Ultra-trail running races pose appreciable physiological challenges, particularly for glucose metabolism. Previous studies that yielded divergent results only measured glycaemia at isolated times. Objectives We aimed to explore the impact of an ultra-endurance race on continuously measured glycaemia and to understand potential physiological mechanisms, as well as the consequences for performance and behavioural alertness. Methods Fifty-five athletes (78% men, 43.7 ± 9.6 years) ran a 156-km ultra-trail race (six 26-km laps, total elevation 6000 m). Participants wore a masked continuous glucose monitoring sensor from the day before the race until 10 days post-race. Blood was taken at rest, during refuelling stops after each lap, and after 24-h recovery. Running intensity (% heart rate reserve), performance (lap times), psychological stress, and behavioural alertness were explored. Linear mixed models and logistic regressions were carried out. Results No higher risk of hypo- or hyperglycaemia was observed during the exercise phases of the race (i.e. excluding stops for scientific measurements and refuelling) compared with resting values. Laps comprising a greater proportion of time spent at maximal aerobic intensity were nevertheless associated with more time > 180 mg/dL (P = 0.021). A major risk of hyperglycaemia appeared during the 48-h post-race period compared with pre-race (P < 0.05), with 31.9% of the participants spending time with values > 180 mg/dL during recovery versus 5.5% during resting. Changes in circulating insulin, cortisol, and free fatty acids followed profiles comparable with those usually observed during traditional aerobic exercise. However, creatine phosphokinase, and to a lesser extent lactate dehydrogenase, increased exponentially during the race (P < 0.001) and remained high at 24-h post-race (P < 0.001; respectively 43.6 and 1.8 times higher vs. resting). Glycaemic metrics did not influence physical performance or behavioural alertness. Conclusion Ultra-endurance athletes were exposed to hyperglycaemia during the 48-h post-race period, possibly linked to muscle damage and inflammation. Strategies to mitigate muscle damage or subsequent inflammation before or after ultra-trail races could limit recovery hyperglycaemia and hence its related adverse health consequences. Trial Registration Number NCT05538442 2022–09-21 retrospectively registered. Graphical abstract


  • Transient Central Facial Palsy at High Altitude: A Case Report

    by Edem Allado, Bruno Chenuel, Jean-Charles Vauthier, Oriane Hily, Sébastien Richard, Mathias Poussel

    Allado, Edem, Bruno Chenuel, Jean-Charles Vauthier, Oriane Hily, Sébastien Richard, and Mathias Poussel. Transient central facial palsy at high altitude: a case report. High Alt Med Biol. 00:000–000, 2020.—High altitude cerebral edema (HACE) is a severe form of acute mountain sickness (AMS). Besides this life-threatening condition, other neurological disorders may develop at high altitude, even if the precise pathophysiological mechanisms generally remain undetermined and are often debated. We report the case of a 34-year-old woman presenting with moderate AMS during an ascent of Mount Kilimanjaro. While descending from the summit, she suddenly experienced focal neurological symptoms of visual blurring, tinnitus, lightheadedness, and the findings of left-sided central facial palsy (flattened nasolabial fold, fall of labial commissure, dysarthria, difficulty in whistling, and facial dysesthesia). These symptoms and signs were confirmed in the field by a physician. Her symptoms regressed spontaneously and completely while continuing to descend. The etiology of this neurological episode at high altitude is discussed. The most probable diagnosis is a transient ischemic attack based on personal and familial vascular history, confirmed unilateral transient central facial palsy and normal results on standard blood work and cerebral magnetic resonance imaging. In this case, migraine should also be considered based on association of headache and transient focal neurological impairment. Overall, special attention should be given to mountaineers presenting with neurological conditions at altitude. Not only HACE should be considered but also the wide spectrum of other neurological conditions that fall outside the usual definition of altitude sickness.

  • Open Access

    Study of the Kinetics of the Determinants of Performance During a Mountain Ultramarathon: Multidisciplinary Protocol of the First Trail Scientifique de Clécy 2021

    by Benoit Mauvieux, Corentin Hingrand, Joffrey Drigny, Amir Hodzic, Pauline Baron, Rémy Hurdiel, Romain Jouffroy, Jean-Charles Vauthier, Mathias Pessiglione, Antonius Wiehler, et al.

    Background: The growing interest of the scientific community in trail running has highlighted the acute effects of practice at the time of these races on isolated aspects of physiological and structural systems; biological, physiological, cognitive, and muscular functions; and the psychological state of athletes. However, no integrative study has been conducted under these conditions with so many participants and monitoring of pre-, per-, and postrace variables for up to 10 days over a distance close to 100 miles. Objective: The aim of this study was to evaluate the kinetics of the performance parameters during a 156 km trail run and 6000 m of elevation gain in pre-, per-, and postrace conditions. The general hypothesis is based on significant alterations in the psychological, physiological, mechanical, biological, and cognitive parameters. Methods: The Trail Scientifique de Clécy took place on November 11, 2021. This prospective experimental study provides a comprehensive exploration of the constraints and adaptations of psychophysiological and sociological variables assessed in real race conditions during a trail running of 156 km on hilly ground and 6000 m of elevation gain (D+). The study protocol allowed for repeatability of study measurements under the same experimental conditions during the race, with the race being divided into 6 identical loops of 26 km and 1000 m D+. Measurements were conducted the day before and the morning of the race, at the end of each lap, after a pit stop, and up to 10 days after the race. A total of 55 participants were included, 43 (78%) men and 12 (22%) women, who were experienced in ultra–trail-running events and with no contraindications to the practice of this sport. Results: The launch of the study was authorized on October 26, 2021, under the trial number 21-0166 after a favorable opinion from the Comité de Protection des Personnes Ouest III (21.09.61/SIRIPH 2G 21.01586.000009). Of the 55 runners enrolled, 41 (75%) completed the race and 14 (25%) dropped out for various reasons, including gastric problems, hypothermia, fatigue, and musculoskeletal injuries. All the measurements for each team were completed in full. The race times (ie, excluding the measurements) ranged from 17.8206 hours for the first runner to 35.9225 hours for the last runner. The average time to complete all measurements for each lap was 64 (SD 3) minutes. Conclusions: The Trail Scientifique de Clécy, by its protocol, allowed for a multidisciplinary approach to the discipline. This approach will allow for the explanation of the studied parameters in relation to each other and observation of the systems of dependence and independence. The initial results are expected in June 2022. International Registered Report Identifier (IRRID): RR1-10.2196/38027